Patient-Led Insulin Dosing Linked to Better Outcomes in Gestational Diabetes

Study finds self-titration leads to faster glycemic control and lower risk of macrosomia compared to clinician-led approach.

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

In a randomized controlled trial, researchers found that individuals with gestational diabetes who titrated their own insulin experienced more rapid glycemic control and lower risks for macrosomia than when clinicians led the insulin titration. Both approaches resulted in similar mean fasting glucose levels before delivery.

Why it matters

The findings suggest patient-led insulin titration may be a more effective approach for managing gestational diabetes, potentially leading to better outcomes for both the mother and baby. This could have important implications for how gestational diabetes is managed in clinical practice.

The details

The study involved 56 adults with gestational diabetes who required insulin between 20 and 31 weeks and 6 days of gestation. Participants were randomly assigned to either patient-led insulin titration, starting at 10 units nightly, or clinician-led insulin titration, with starting doses and adjustments made at the clinician's discretion. In the patient-led group, participants adjusted their insulin dose based on fasting glucose levels. The primary outcome was the mean fasting glucose level at 36 weeks of gestation or during the week before delivery for preterm delivery.

  • The study was conducted over a 2-year period starting in October 2023.

The players

Xiao-Yu Wang, MD

The lead author of the study, from the Department of Obstetrics and Gynecology at the Northwestern University in Chicago.

Got photos? Submit your photos here. ›

What they’re saying

“[P]atient-led self-insulin titration for GDM [gestational diabetes mellitus]...was associated with more rapid achievement of glycemic control and a significantly lower risk of macrosomia and LGA [large-for-gestational-age] birth weight.”

— Xiao-Yu Wang, MD, Lead Author (Obstetrics & Gynecology)

The takeaway

The study suggests patient-led insulin titration may be a more effective approach for managing gestational diabetes, leading to faster glycemic control and lower risks of complications like macrosomia. This could have important implications for clinical practice and how gestational diabetes is managed.